Trial explores potential of therapy in treating multiple cancer types Bayer has begun a phase 1 clinical trial for BAY3498264 ...
AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended by NICE for treating adults with ...
The positive pre-clinical results underpin the development of POLB 001 for Phase 2 clinical trials as a prophylactic for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback